Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Carl Maki and Jeffrey Borgia.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.228 |
|
|
|
-
Duan L, Calhoun S, Perez RE, Macias V, Mir F, Pergande MR, Gattuso P, Borgia JA, Maki CG. Prolyl Carboxypeptidase Maintains Receptor Tyrosine Kinase Signaling and Is a Potential Therapeutic Target in Triple Negative Breast Cancer. Cancers (Basel). 2022 Jan 31; 14(3).
Score: 0.228